References
- Charney P, Walsh JM, Nattinger AB. Update in women's health. Ann Intern Med 1998; 129(7): 551–8
- Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998; 158(6): 617–21
- Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 1996; 334(20): 1311–5
- Haynes SG, Feinleib M. Women, work and coronary heart disease: prospective findings from the Framingham Heart Study. Am J Public Health 1980; 70(2): 133–41
- Rosenfeld JA. Impact of maternal employment on the health of the family. Curr Probl Pediatr 1995; 25(1): 4–11
- Eaker ED. Psychosocial risk factors for coronary heart disease in women. Cardiol Clin 1998; 16(1): 103–11
- Dorn JM, Schisterman EF, Winkelstein W, et al. Body mass index and mortality in a general population sample of men and women: the Buffalo Health Study. Am J Epidemiol 1997; 146(11): 919–31
- Hennekens CH. Risk factors for coronary heart disease in women. Cardiol Clin 1998; 16 (1): 1–8
- Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J 1998; 19(Suppl A): 45–52
- Wenger NK. Coronary heart disease: an older woman's major health risk. BMJ 1997; 315(7115): 1085–90
- Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 1993; 119(10):992–1000.
- Willet WC, Green A, Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317(21): 1303–9
- LaRosa JC. Triglycerides and coronary risk in women and the elderly. Arch Intern Med 1997; 157(9): 961–8
- Thomas JL, Braus PA. Coronary artery disease in women: a historical perspective. Arch Intern Med 1998; 158(4): 333–7
- Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279(20): 1615–22.
- Stefanick ML, Mackey S, Sheehan M, et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339(l): 12–20
- Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335(14): 1001–9
- UK Prospective Diabetes Study 27: plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997; 20(11): 1683–7
- Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997; 336(25): 1769–75
- Abu-Halawa SA, Thompson K, Kirkeeide RL, et al. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women. Am J Cardiol 1998; 82(4): 409–13
- Wenger NK. Postmenopausal hormone therapy: is it useful for coronary prevention? Cardiol Clin 1998; 16(1): 17–25
- Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 1998; 280(7): 605–13
- Newnham HH, Silberberg J. Does estrogen therapy have a role in cardiovascular prevention? Am Fam Physician 1999; 59(5): 1125–6, 1131
- Manson JE, Stampfer MJ, Colditz GA, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266(4): 521–7